INDP earnings: next report 2026-08-17, real EPS beat/miss history, analyst consensus Buy, P/E -0.42. Updated 2026-07-23.
Indaptus Therapeutics (INDP) Research Hub
Indaptus Therapeutics (INDP) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 2.77 USD (+33.17%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -0.42, market cap 0.00B. This hub links to the full technical, earnings and options research available for INDP.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 2.77 USD (+33.17%) |
| 52-week range | 0.925 USD – 4.94 USD |
| Trend regime | Range |
| 14-day RSI | 81.9 (Overbought) |
| Trailing P/E | -0.42 |
| Market cap | 0.00B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-17 |
Available research for INDP
Covered Call on INDP: how it works, illustrative setup around the real 2.77 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on INDP: how it works, illustrative setup around the real 2.77 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on INDP: how it works, illustrative setup around the real 2.77 USD price, max profit/loss, breakeven and when to use it. Educational.
INDP technical analysis: range, last 2.77 USD, RSI 81.9, 52w range 0.925 USD–4.94 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is INDP in?
Indaptus Therapeutics (INDP) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is INDP in an uptrend or downtrend?
As of 2026-09-11, INDP is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is INDP's trailing P/E ratio?
INDP's trailing P/E is -0.42, with a market cap of 0.00B. See the earnings research page for full valuation detail.
When does INDP next report earnings?
INDP is next scheduled to report earnings on 2026-08-17, with a consensus EPS estimate of -1.57 USD.